Endologix
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Endologix sits in the top decile of US sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count).
Endologix: 17 sponsored US clinical trials, 3 recruiting.
Endologix sponsors 17 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 11 completed. The most-studied condition in this pipeline is Abdominal Aortic Aneurysm, with 3 trials.
Top-decile sponsor footprint
Endologix ranks in the top decile of sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
11 of 11 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
17 total, page 1 of 1
The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)
NCT06315023
The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 System
NCT06990048
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
NCT05064540
Chimney EndoVascular Aneurysm Sealing Of New Expanded Indication
NCT04252573
TORUS 2 IDE Clinical Study
NCT04130737
EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study
NCT03298477
Detour2 Continued Access Study
NCT04625660
The DETOUR 2 Clinical Trial
NCT03119233
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft Investigational Device Exemption (IDE) Study
NCT02949297
Post-Market Study to Assess Outcomes of Patients Treated With AFX System Compared to Other EVAR Devices
NCT02407457
Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System
NCT01726257
Safety and Effectiveness Trial of the Ventana Fenestrated Stent Graft System
NCT01491945
Feasibility and Safety Study of the Endologix Fenestrated Stent Graft System
NCT01348828
Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial
NCT01070069
34mm Cuff Study for Endovascular Repair of Abdominal Aortic Aneurysms
NCT00706394
Suprarenal Proximal Cuff Study for Treatment of Abdominal Aortic Aneurysm
NCT00739401
Powerlink Bifurcated Stent Graft Long-Term Follow-up Study
NCT00543270
Therapeutic Areas
What is open in the Endologix pipeline
3 recruiting of 17 indexed (18% open); 11 completed (65%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Abdominal Aortic Aneurysm (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Endologix: open-pipeline peers nationwide
Peers matched on 17 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Endologix sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 17 trials (± recruiting share)
- Achieve Life Sciences · 17 trials · 0% recruiting
- BioDelivery Sciences International · 17 trials · 6% recruiting
- Chugai Pharmaceutical · 17 trials · 24% recruiting
- ConvaTec · 17 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- National Institute on Deafness and Other Communication Disorders (NIDCD) · 18% recruiting · 34 trials
- NICHD Pelvic Floor Disorders Network · 18% recruiting · 17 trials
- Sanford Health · 18% recruiting · 34 trials
- Woman's · 18% recruiting · 17 trials
Related
What to do with this Endologix page
17 registered trials is a research-attention snapshot, not an endorsement of Endologix or any single study.
- 3 of Endologix's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Abdominal Aortic Aneurysm is the condition Endologix studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Abdominal Aortic Aneurysm trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Endologix pipeline card: 17 registered trials from official public datasets.Report a data error.